Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 26

1.

High titer MVA and influenza A virus production using a hybrid fed-batch/perfusion strategy with an ATF system.

Vázquez-Ramírez D, Jordan I, Sandig V, Genzel Y, Reichl U.

Appl Microbiol Biotechnol. 2019 Apr;103(7):3025-3035. doi: 10.1007/s00253-019-09694-2. Epub 2019 Feb 23.

2.

mRNA as novel technology for passive immunotherapy.

Schlake T, Thess A, Thran M, Jordan I.

Cell Mol Life Sci. 2019 Jan;76(2):301-328. doi: 10.1007/s00018-018-2935-4. Epub 2018 Oct 17. Review.

3.

High-cell-density cultivations to increase MVA virus production.

Vázquez-Ramírez D, Genzel Y, Jordan I, Sandig V, Reichl U.

Vaccine. 2018 May 24;36(22):3124-3133. doi: 10.1016/j.vaccine.2017.10.112. Epub 2018 Feb 9.

PMID:
29433897
4.

Efficient and stable production of Modified Vaccinia Ankara virus in two-stage semi-continuous and in continuous stirred tank cultivation systems.

Tapia F, Jordan I, Genzel Y, Reichl U.

PLoS One. 2017 Aug 24;12(8):e0182553. doi: 10.1371/journal.pone.0182553. eCollection 2017.

5.

Innate Immune Responses of Bat and Human Cells to Filoviruses: Commonalities and Distinctions.

Kuzmin IV, Schwarz TM, Ilinykh PA, Jordan I, Ksiazek TG, Sachidanandam R, Basler CF, Bukreyev A.

J Virol. 2017 Mar 29;91(8). pii: e02471-16. doi: 10.1128/JVI.02471-16. Print 2017 Apr 15.

6.

Continuous cell lines from the Muscovy duck as potential replacement for primary cells in the production of avian vaccines.

Jordan I, John K, Höwing K, Lohr V, Penzes Z, Gubucz-Sombor E, Fu Y, Gao P, Harder T, Zádori Z, Sandig V.

Avian Pathol. 2016;45(2):137-55. doi: 10.1080/03079457.2016.1138280.

PMID:
26814192
7.

Impaired antiviral response of adenovirus-transformed cell lines supports virus replication.

Bachmann M, Breitwieser T, Lipps C, Wirth D, Jordan I, Reichl U, Frensing T.

J Gen Virol. 2016 Feb;97(2):293-8. doi: 10.1099/jgv.0.000361. Epub 2015 Dec 8.

PMID:
26647282
8.

CD26/DPP4 cell-surface expression in bat cells correlates with bat cell susceptibility to Middle East respiratory syndrome coronavirus (MERS-CoV) infection and evolution of persistent infection.

Caì Y, Yú SQ, Postnikova EN, Mazur S, Bernbaum JG, Burk R, Zhāng T, Radoshitzky SR, Müller MA, Jordan I, Bollinger L, Hensley LE, Jahrling PB, Kuhn JH.

PLoS One. 2014 Nov 19;9(11):e112060. doi: 10.1371/journal.pone.0112060. eCollection 2014.

9.

Influenza A virus polymerase is a site for adaptive changes during experimental evolution in bat cells.

Poole DS, Yú S, Caì Y, Dinis JM, Müller MA, Jordan I, Friedrich TC, Kuhn JH, Mehle A.

J Virol. 2014 Nov;88(21):12572-85. doi: 10.1128/JVI.01857-14. Epub 2014 Aug 20.

10.

The avian cell line AGE1.CR.pIX characterized by metabolic flux analysis.

Lohr V, Hädicke O, Genzel Y, Jordan I, Büntemeyer H, Klamt S, Reichl U.

BMC Biotechnol. 2014 Jul 30;14:72. doi: 10.1186/1472-6750-14-72.

11.

Propagation of viruses infecting waterfowl on continuous cell lines of Muscovy duck (Cairina moschata) origin.

Mészáros I, Tóth R, Bálint A, Dán A, Jordan I, Zádori Z.

Avian Pathol. 2014;43(4):379-86. doi: 10.1080/03079457.2014.939941.

PMID:
24992264
12.

Matrix and backstage: cellular substrates for viral vaccines.

Jordan I, Sandig V.

Viruses. 2014 Apr 11;6(4):1672-700. doi: 10.3390/v6041672. Review.

13.

High cell density cultivations by alternating tangential flow (ATF) perfusion for influenza A virus production using suspension cells.

Genzel Y, Vogel T, Buck J, Behrendt I, Ramirez DV, Schiedner G, Jordan I, Reichl U.

Vaccine. 2014 May 19;32(24):2770-81. doi: 10.1016/j.vaccine.2014.02.016. Epub 2014 Feb 25.

PMID:
24583003
14.

Elements in the Development of a Production Process for Modified Vaccinia Virus Ankara.

Jordan I, Lohr V, Genzel Y, Reichl U, Sandig V.

Microorganisms. 2013 Nov 1;1(1):100-121. Review.

15.

Continuous influenza virus production in cell culture shows a periodic accumulation of defective interfering particles.

Frensing T, Heldt FS, Pflugmacher A, Behrendt I, Jordan I, Flockerzi D, Genzel Y, Reichl U.

PLoS One. 2013 Sep 5;8(9):e72288. doi: 10.1371/journal.pone.0072288. eCollection 2013.

16.

A genotype of modified vaccinia Ankara (MVA) that facilitates replication in suspension cultures in chemically defined medium.

Jordan I, Horn D, John K, Sandig V.

Viruses. 2013 Jan 21;5(1):321-39. doi: 10.3390/v5010321.

17.

Live attenuated influenza viruses produced in a suspension process with avian AGE1.CR.pIX cells.

Lohr V, Genzel Y, Jordan I, Katinger D, Mahr S, Sandig V, Reichl U.

BMC Biotechnol. 2012 Oct 30;12:79. doi: 10.1186/1472-6750-12-79.

18.

Fucose-targeted glycoengineering of pharmaceutical cell lines.

Ogorek C, Jordan I, Sandig V, von Horsten HH.

Methods Mol Biol. 2012;907:507-17. doi: 10.1007/978-1-61779-974-7_29.

PMID:
22907371
19.

Authentication of the R06E fruit bat cell line.

Jordan I, Munster VJ, Sandig V.

Viruses. 2012 May;4(5):889-900. doi: 10.3390/v4050889. Epub 2012 May 23.

20.

Highly efficient, chemically defined and fully scalable biphasic production of vaccine viruses.

Jordan I, Sandig V.

BMC Proc. 2011 Nov 22;5 Suppl 8:O1. doi: 10.1186/1753-6561-5-S8-O1. eCollection 2011. No abstract available.

Supplemental Content

Loading ...
Support Center